Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Candida glabrata: an emergent opportunist in vulvovaginitis.

Buitrón García-Figueroa R, Araiza-Santibáñez J, Basurto-Kuba E, Bonifaz-Trujillo A.

Cir Cir. 2009 Nov-Dec;77(6):423-7. English, Spanish.

PMID:
20433786
2.

Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.

Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, Kochupillai N.

J Infect. 2006 Feb;52(2):111-7.

PMID:
15908007
4.
5.

Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.

Lattif AA, Mukhopadhyay G, Banerjee U, Goswami R, Prasad R.

J Microbiol Immunol Infect. 2011 Jun;44(3):166-71. doi: 10.1016/j.jmii.2011.01.020. Epub 2011 Jan 18. Erratum in: J Microbiol Immunol Infect. 2012 Oct;45(5):393. Mukhopadhyay, Gauranga [added]; Banerjee, Uma [added]; Goswami, Ravinder [added]; Prasad, Rajendra [added].

6.

Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.

Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.

Diabetes Care. 2007 Feb;30(2):312-7.

PMID:
17259500
7.

Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.

Martins HP, da Silva MC, Paiva LC, Svidzinski TI, Consolaro ME.

Acta Derm Venereol. 2012 Jan;92(1):78-82. doi: 10.2340/00015555-1194.

8.

[Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis].

Buitrón García R, Romero Cabello R, Cruz Talonia F, Bonifaz A, Zarama Marquez F.

Ginecol Obstet Mex. 2002 Sep;70:431-6. Spanish.

PMID:
12448051
9.

[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].

Gomez-Moyano E, Cid Lama A, Fernández Ballesteros MD, Lova Navarro M, Vera Casaño A, Crespo Erchiga V.

Rev Iberoam Micol. 2013 Jan 3;30(1):61-3. doi: 10.1016/j.riam.2012.07.004. Epub 2012 Aug 8. Spanish.

PMID:
22885618
10.

Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.

Danby CS, Boikov D, Rautemaa-Richardson R, Sobel JD.

Antimicrob Agents Chemother. 2012 Mar;56(3):1403-6. doi: 10.1128/AAC.05025-11. Epub 2012 Jan 9.

11.

[Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].

Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.

Rev Argent Microbiol. 2001 Oct-Dec;33(4):217-22. Spanish.

PMID:
11833253
12.

Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.

Sojakova M, Liptajova D, Borovsky M, Subik J.

Mycopathologia. 2004 Feb;157(2):163-9.

PMID:
15119851
13.

[Identification and susceptibility against fluconazole and albaconazole of 100 yeasts' strains isolated from vaginal discharge].

Arechavala AI, Bianchi MH, Robles AM, Santiso G, Negroni R.

Rev Iberoam Micol. 2007 Dec 31;24(4):305-8. Spanish.

14.

The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population.

Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M.

Eur J Obstet Gynecol Reprod Biol. 2011 Apr;155(2):199-203. doi: 10.1016/j.ejogrb.2010.11.022. Epub 2010 Dec 30.

PMID:
21194828
15.

A 5-year (2000-2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria.

Paulitsch A, Weger W, Ginter-Hanselmayer G, Marth E, Buzina W.

Mycoses. 2006 Nov;49(6):471-5.

PMID:
17022763
16.

Susceptibility of Candida species isolated from female prostitutes with vulvovaginitis to antifungal agents and boric acid.

Otero L, Fleites A, Méndez FJ, Palacio V, Vázquez F.

Eur J Clin Microbiol Infect Dis. 1999 Jan;18(1):59-61.

PMID:
10192716
17.

[Candida glabrata : pathogenicity and therapy update].

Tietz HJ.

Hautarzt. 2012 Nov;63(11):868-71. doi: 10.1007/s00105-012-2377-0. German.

PMID:
22925897
18.

Antifungal efficacy of propolis against fluconazole-resistant Candida glabrata isolates obtained from women with recurrent vulvovaginal candidiasis.

Shokri H, Khosravi AR, Yalfani R.

Int J Gynaecol Obstet. 2011 Aug;114(2):158-9. doi: 10.1016/j.ijgo.2011.02.019. Epub 2011 Jun 12. No abstract available.

PMID:
21669419
19.

Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.

Cohen Y, Karoubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, Clec'h C.

Crit Care Med. 2010 Mar;38(3):826-30. doi: 10.1097/CCM.0b013e3181cc4734.

PMID:
20042858
20.

[Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].

Mujica MT, Finquelievich JL, Jewtuchowicz V, Iovannitti CA.

Rev Argent Microbiol. 2004 Jul-Sep;36(3):107-12. Spanish.

PMID:
15559191
Items per page

Supplemental Content

Write to the Help Desk